Patent details

EP2236155 Title: Decreasing potential iatrogenic risks associated with influenza vaccines

Basic Information

Publication number:
EP2236155
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP100753102
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Decreasing potential iatrogenic risks associated with influenza vaccines
French Title of Invention:
Réduction de risques iatrogènes potentiels associés aux vaccins contre la grippe
German Title of Invention:
Verminderung von potentiellen iatrogenen Risiken in Verbindung mit Influenza Impfstoffen
SPC Number:

Dates

Filing date:
09/09/2005
Grant date:
16/05/2012
EP Publication Date:
16/05/2012
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/10/2010
EP B1 Publication Date:
16/05/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
09/09/2014
Expiration date:
09/09/2025
Renunciation date:
Revocation date:
21/05/2019
Annulment date:

Owner

From:
09/09/2005
 
 

Name:
Novartis Vaccines and Diagnostics GmbH
Address:
Emil-von-Behring-Strasse 76, 35041 Marburg, Germany (DE)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
06/06/2012
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
Gregersen Jens Peter
Address:
Germany (DE)

Priority

Priority Number:
04255471
Priority Date:
09/09/2004
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
A61K 39/145;

Publication

European Patent Bulletin

Issue number:
201937
Publication date:
11/09/2019
Description:
Revocation of the European patent
Filing date Document type Number of pages